Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06969404) titled 'Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patie... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06969976) titled 'the Effect of Dry Cupping on Muscle Strength in Normal Individual' on May 2. S... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06971055) titled 'Moringa Oleifera vs Sodium Hypochlorite for Root Canal Irrigation in Nonvital P... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06966375) titled 'Worldwide Yearly Screening for Hypospadias' on May 2. Study Type: Intervention... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06966011) titled 'Rebound Pain After Peripheral Nerve Blocks in Total Knee Arthroplasty' on May 2... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06969339) titled 'Unilateral Posterior Wedge Closing Vertebral Column Resection for Treatment of ... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06971068) titled 'Vacuum-assisted Laser Ablation (VALA) for Treatment of Large Saphenous Veins' o... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06976996) titled 'Efficacy of Esketamine Combined With Different General Anesthetics on Quality o... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (ACTRN12625000402448) titled 'The effectiveness of calcium versus ibuprofen in reducing pain among a ... Read More
Geneva, May 28 -- International Clinical Trials Registry received information related to the study (ISRCTN96603462) titled 'Phase 1 Trial: Quotient Code QSC303303, Sponsor Code LMNL6511C1002' on May 2... Read More